Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)
A phase 2 trial of Carfilzomib, Venetoclax, Dexamethasone in multiple myeloma, run by AbbVie, active and no longer recruiting.
Overview
Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM) is a phase 2 interventional study registered as NCT02899052 by AbbVie, with 120 participants planned, started 2017-01-19 and due to reach its primary completion in 2027-06. Interventions recorded: Carfilzomib, Venetoclax, Dexamethasone. Conditions listed: Multiple Myeloma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex)
Shares Dexamethasone, AbbVie (incl. ImmunoGen, Capstan), Venetoclax, Multiple myeloma.
- TrialA Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractor
Shares Dexamethasone, AbbVie (incl. ImmunoGen, Capstan), Venetoclax, Multiple myeloma.
- TrialAn Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
Shares AbbVie (incl. ImmunoGen, Capstan), Venetoclax, Multiple myeloma.
- TrialA Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants W
Shares Carfilzomib, Dexamethasone, Multiple myeloma.
- TrialA Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory
Shares Carfilzomib, Dexamethasone, Multiple myeloma.
- TrialA Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-spe
Shares Carfilzomib, Dexamethasone, AbbVie (incl. ImmunoGen, Capstan), Multiple myeloma.
- TrialStudy Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refracto
Shares Carfilzomib, Dexamethasone, AbbVie (incl. ImmunoGen, Capstan), Multiple myeloma.
- TrialA Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lena
Shares Dexamethasone, AbbVie (incl. ImmunoGen, Capstan), Multiple myeloma.